Larvol Delta - Open-Label-Phase-12-Study-of-Tasquinimod-in-Patients-With-Primary-Myelofibrosis-PMF-PostPolycythemia-Vera-Myelofibrosis-PostPV-MF-or-PostEssential-Thrombocytosis-Myelofibrosis-PostET-MF

Jakafi (ruxolitinib) - Incyte

tasquinimod (ABR-215050) - Active Biotech

http://clinicaltrials.gov/ct2/show/NCT06327100

Feb 11, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next